135 related articles for article (PubMed ID: 38279594)
21. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
22. Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab.
Morales AV; Advani R; Horwitz SM; Riaz N; Reddy S; Hoppe RT; Kim YH
J Am Acad Dermatol; 2008 Dec; 59(6):953-7. PubMed ID: 18817999
[TBL] [Abstract][Full Text] [Related]
23. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
Senff NJ; Noordijk EM; Kim YH; Bagot M; Berti E; Cerroni L; Dummer R; Duvic M; Hoppe RT; Pimpinelli N; Rosen ST; Vermeer MH; Whittaker S; Willemze R; ;
Blood; 2008 Sep; 112(5):1600-9. PubMed ID: 18567836
[TBL] [Abstract][Full Text] [Related]
24. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma.
Monsálvez V; Montes-Moreno S; Artiga MJ; Rodríguez ME; Sanchez-Espiridion B; Lozano M; Fernández-de-Misa R; Rodríguez-Peralto JL; Piris MA; Ortíz-Romero PL
Mod Pathol; 2013 Feb; 26(2):171-81. PubMed ID: 22936066
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.
Dobos G; de Masson A; Ram-Wolff C; Beylot-Barry M; Pham-Ledard A; Ortonne N; Ingen-Housz-Oro S; Battistella M; d'Incan M; Rouanet J; Franck F; Vignon-Pennamen MD; Franck N; Carlotti A; Boulinguez S; Lamant L; Petrella T; Dalac S; Joly P; Courville P; Rivet J; Dereure O; Amatore F; Taix S; Grange F; Durlach A; Quéreux G; Josselin N; Moulonguet I; Mortier L; Dubois R; Maubec E; Laroche L; Michel L; Templier I; Barete S; Nardin C; Augereau O; Vergier B; Bagot M;
Br J Dermatol; 2021 Jun; 184(6):1059-1067. PubMed ID: 33131055
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous B-cell lymphomas- clinical and histopathologic features, differential diagnosis, and treatment.
Chen ST; Barnes J; Duncan L
Semin Cutan Med Surg; 2018 Mar; 37(1):49-55. PubMed ID: 29719020
[TBL] [Abstract][Full Text] [Related]
28. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study.
Nguyen M; LeWitt T; Pang Y; Bagnowski K; Espinosa ML; Choi J; Guitart J; Liszewski W; Zhou XA
Arch Dermatol Res; 2023 Mar; 315(2):275-278. PubMed ID: 35668201
[TBL] [Abstract][Full Text] [Related]
29. Frequency of central nervous system involvement in primary cutaneous B-cell lymphoma.
Bekkenk MW; Postma TJ; Meijer CJ; Willemze R
Cancer; 2000 Aug; 89(4):913-9. PubMed ID: 10951357
[TBL] [Abstract][Full Text] [Related]
30. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas.
Urosevic M; Willers J; Mueller B; Kempf W; Burg G; Dummer R
Blood; 2002 Jan; 99(2):609-17. PubMed ID: 11781245
[TBL] [Abstract][Full Text] [Related]
31. Association of Quality of Life With Surgical Excision of Early-Stage Melanoma of the Head and Neck.
Mori S; Blank NR; Connolly KL; Dusza SW; Nehal KS; Rossi AM; Lee EH
JAMA Dermatol; 2019 Jan; 155(1):85-89. PubMed ID: 30422228
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of intravenous therapy with rituximab in patients with primary cutaneous B-cell lymphomas.
Brandenburg A; Humme D; Terhorst D; Gellrich S; Sterry W; Beyer M
Br J Dermatol; 2013 Nov; 169(5):1126-32. PubMed ID: 23796422
[TBL] [Abstract][Full Text] [Related]
33. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects.
Rijlaarsdam U; Bakels V; van Oostveen JW; Gordijn RJ; Geerts ML; Meijer CJ; Willemze R
J Invest Dermatol; 1992 Dec; 99(6):749-54. PubMed ID: 1469288
[TBL] [Abstract][Full Text] [Related]
34. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
35. Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil.
Bittencourt AL; Oliveira PD; Andrade AC; Santos TC; Oliveira RF; Farré L; Araujo I
Am J Clin Pathol; 2013 Sep; 140(3):348-54. PubMed ID: 23955453
[TBL] [Abstract][Full Text] [Related]
36. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
37. CD30 expression in cutaneous B-cell lymphomas.
Afolayan-Oloye O; Zhao L; Tejasvi T; Chan MP; Harms PW; Fullen DR; Wilcox RA; Hristov AC
J Cutan Pathol; 2023 Sep; 50(9):819-827. PubMed ID: 37290910
[TBL] [Abstract][Full Text] [Related]
38. Juvenile onset of primary low-grade cutaneous B-cell lymphoma.
Amitay-Laish I; Feinmesser M; Ben-Amitai D; David M; Manor Y; Kidron D; Barzilai A; Hodak E
Br J Dermatol; 2009 Jul; 161(1):140-7. PubMed ID: 19416255
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003.
Riou-Gotta MO; Fournier E; Mermet I; Pelletier F; Humbert P; Danzon A; Aubin F
Leuk Lymphoma; 2008 Aug; 49(8):1537-44. PubMed ID: 18766967
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
